January 28, 2026

How to embrace interventional glaucoma "IG" in your practice with iTrack Advance

Join us for a deep dive into canaloplasty in the era of interventional glaucoma or IG.

The Ophthalmologist

January 16, 2026

New CAR T-Cell Therapy Shows Promise as ‘Magic Bullet’ for Patients with Relapsed/Refractory AML — Even After Transplant

A phase 1 clinical trial underway exclusively at Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., is evaluating a new chimeric antigen receptor (CAR) T-cell therapy that could dramatically transform the treatment of relapsed or refractory acute myeloid leukemia (AML).

Roswell Park Comprehensive Cancer Center

January 16, 2026

Pediatric Subspecialist Shortages: Where Does Pediatric Ophthalmology Stand?

Speaker:  Grayson B. Ashby, MD

Mayo Clinic

January 16, 2026

The Road Less Travelled: Transorbital Neurosurgical Approaches

Speaker:  Lilly H. Wagner, MD

Mayo Clinic

January 16, 2026

Post Cataract Surgery Endophthalmitis in the Intracameral Antibiotic Era: What Else Can We Do in 2025?

Speaker:  Michael Mahr, MD

Mayo Clinic

January 16, 2026

Novotech Appoints Anand Tharmaratnam as CEO

New leader will be based at the company’s new global headquarters in Singapore

The Medicine Maker

January 16, 2026

How to Test Whether Antibiotics Actually Work

New testing method predicts antibiotic treatment success by measuring bacterial killing speed

The Pathologist

January 16, 2026

AI in Pathology Fails Without Pathologists

Why clinical expertise is essential to computational pathology success

The Pathologist

January 16, 2026

Discussing the Big Ideas in Medicine Manufacturing: Part II

More experts share their thoughts on the next “big ideas” that they think will shape the near future of therapy developments.

The Medicine Maker